DE69636393D1 - Montirelin zur verhinderung der schlafapnoe - Google Patents

Montirelin zur verhinderung der schlafapnoe

Info

Publication number
DE69636393D1
DE69636393D1 DE69636393T DE69636393T DE69636393D1 DE 69636393 D1 DE69636393 D1 DE 69636393D1 DE 69636393 T DE69636393 T DE 69636393T DE 69636393 T DE69636393 T DE 69636393T DE 69636393 D1 DE69636393 D1 DE 69636393D1
Authority
DE
Germany
Prior art keywords
pct
sleep apnea
montirelin
prevention
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636393T
Other languages
English (en)
Other versions
DE69636393T2 (de
Inventor
Andrew Winokur
I Pack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Application granted granted Critical
Publication of DE69636393D1 publication Critical patent/DE69636393D1/de
Publication of DE69636393T2 publication Critical patent/DE69636393T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Harvester Elements (AREA)
  • Control Of Positive-Displacement Air Blowers (AREA)
DE69636393T 1995-10-24 1996-10-24 Montirelin zur verhinderung der schlafapnoe Expired - Fee Related DE69636393T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US603295P 1995-10-24 1995-10-24
US6032P 1995-10-24
PCT/US1996/017184 WO1997015309A1 (en) 1995-10-24 1996-10-24 Method of inhibiting sleep apnea

Publications (2)

Publication Number Publication Date
DE69636393D1 true DE69636393D1 (de) 2006-09-07
DE69636393T2 DE69636393T2 (de) 2006-12-07

Family

ID=21718957

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636393T Expired - Fee Related DE69636393T2 (de) 1995-10-24 1996-10-24 Montirelin zur verhinderung der schlafapnoe

Country Status (12)

Country Link
US (1) US5968932A (de)
EP (1) EP0866711B1 (de)
JP (1) JPH11515015A (de)
AT (1) ATE333880T1 (de)
AU (1) AU714270B2 (de)
CA (1) CA2235854A1 (de)
DE (1) DE69636393T2 (de)
DK (1) DK0866711T3 (de)
ES (1) ES2268712T3 (de)
HK (1) HK1015283A1 (de)
PT (1) PT866711E (de)
WO (1) WO1997015309A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289816T1 (de) * 1997-11-14 2005-03-15 Akzo Nobel Nv Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE10025949A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Arzneimittel zur Bekämpfung von Atemdepression
DE102004010516A1 (de) * 2004-03-04 2005-09-22 Bayer Technology Services Gmbh Verbessertes Verfahren zur zeitlichen Dosierung von Arzneistoffen
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
SG11202007226UA (en) 2018-01-30 2020-08-28 Apnimed Inc Delaware Methods and compositions for treating sleep apnea
WO2021202906A1 (en) * 2020-04-02 2021-10-07 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE408300B (sv) * 1974-10-16 1979-06-05 Gruenenthal Chemie Sett att framstella nya dipeptidderivat

Also Published As

Publication number Publication date
AU7477096A (en) 1997-05-15
ATE333880T1 (de) 2006-08-15
EP0866711A1 (de) 1998-09-30
WO1997015309A1 (en) 1997-05-01
DK0866711T3 (da) 2006-11-27
DE69636393T2 (de) 2006-12-07
AU714270B2 (en) 1999-12-23
PT866711E (pt) 2006-12-29
EP0866711A4 (de) 2003-04-16
JPH11515015A (ja) 1999-12-21
EP0866711B1 (de) 2006-07-26
ES2268712T3 (es) 2007-03-16
US5968932A (en) 1999-10-19
HK1015283A1 (en) 1999-10-15
CA2235854A1 (en) 1997-05-01

Similar Documents

Publication Publication Date Title
FI954609A (fi) 1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
ES2113652T3 (es) Pamoato de risperidona.
DE69635459D1 (de) Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes
UA29451C2 (uk) Спосіб збереження або збільшення щільності кістки або інгібування втрати кісткової маси
ATE226436T1 (de) Neue verwendung von dexmedetomidin
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69636393D1 (de) Montirelin zur verhinderung der schlafapnoe
DE69612510D1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
BR9509975A (pt) Formulação farmacêutica
TR199701497T1 (xx) Beyin �demini �nleyen terkip.
DE69710574D1 (de) Diclofenac/gamma-cyclodextrin klathrat komponente
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
SG42910A1 (en) Benzopyrans
PL309593A1 (en) Application of rilusole as a radiorestaurantor
NO964921D0 (no) Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse
BG100531A (en) Method for inhibition of photodecomposition of 3-substituted 2-oxindoles

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee